Torrent Pharmaceuticals Ltd.

NSE: TORNTPHARM | BSE: 500420

₹4,611.00

up-down-arrow ₹0.30 (0.01%)

As on 19-Nov-2026IST

Market cap

info icon

₹1,75,578 Cr

Revenue (TTM)

info icon

₹17,400 Cr

P/E Ratio

info icon

82.7

P/B Ratio

info icon

9.6

Div. Yield

info icon

0.8 %

Value Research Rating

Quality Score fund-quick-summary-circle

Quality Score6/10

Growth Score fund-quick-summary-circle

Growth Score6/10

Valuation Score fund-quick-summary-circle

Valuation Score3/10

Momentum Score fund-quick-summary-circle

Momentum Score9/10

Torrent Pharma Share Price

Compare

High: Low: Return:

High: Low: Return:

Max: Min: Median:

Max: Min: Median:

loading...
loading...
loading...
loading...
loading...
loading...
loading...
loading...

Stock Range

Today’s Range

Low: 4,592.60 High: 4,670.30

52 Week Range

Low: 3,672.30 High: 5,250.00

Liquidityliquidity High

Low Moderate High

Fundamentals

  • Net Profit (TTM)Net Profit (TTM) information

    ₹2,124 Cr

  • ROEROE information

    26.8 %

  • ROCEROCE information

    19.3 %

  • Industry P/EIndustry P/E information

    32.77

  • EV/EBITDAEV/EBITDA information

    32.9

  • Debt to EquityDebt to Equity information

    1.8

  • Book ValueBook Value information

    ₹483

  • EPSEPS information

    ₹63.4

  • Face valueFace value information

    5

  • Shares outstandingShares outstanding information

    380,367,856

10 Years Aggregate

CFO

₹20,144.35 Cr

EBITDA

₹26,041.60 Cr

Net Profit

₹12,052.85 Cr

Performance

Company
YTD
1 Month
3 Months
1 Year
3 Years
5 Years
10 Years
Torrent Pharma
19.8 1.1 -7.2 21.6 30.3 27.0 21.5
BSE Sensex
-2.0 11.1 7.5 -2.0 8.1 6.8 12.2
BSE Healthcare
21.9 9.6 4.1 18.8 21.5 16.0 13.3
As on 19-Nov-2026
Company
2025
2024
2023
2022
2021
2020
2019
Torrent Pharma
12.6 46.3 48.7 -5.4 17.3 52.0 4.1
BSE Sensex
9.1 8.1 18.7 4.4 22.0 15.8 14.4
BSE Healthcare
-3.3 43.1 37.0 -12.1 20.9 61.4 -3.5

Essential Checks

View Details

Is there a threat to the company's solvency?

Can creative accounting be detected through the financial numbers?

How did the company perform in the last one year?

Financials

View Details
loading...

*All values are in (₹ Cr)

loading...

*All values are in (₹ Cr)

loading...

*All values are in (₹ Cr)

Key Ratios

View Details
loading...

loading...

loading...

5Y Avg -- 3Y Avg -- TTM --

loading...

P/E Ratio

--

--Min --Median --Max

loading...

P/B Ratio

--

--Min --Median --Max

loading...

Earnings Yield (%)

--

Earnings Yield (%) = EBIT / Enterprise value

PEG Ratio

--

Price = Price / Earnings to growth ratio

loading...

loading...

loading...

Peers

View Details
Company
Price (₹) Market Cap (₹ Cr) Revenue (TTM) Net Profit (TTM) OPM (%) ROE (%) P/E P/B
Torrent Pharma
4,611.0 1,75,577.8 17,400.0 2,099.0 22.2 16.5 82.7 9.6
5,145.0 61,516.2 15,632.3 2,094.4 17.3 15.1 29.7 4.1
1,805.7 1,03,970.8 36,912.9 3,993.1 15.2 10.5 26.1 2.6
363.7 59,052.0 17,414.5 340.3 8.0 -0.3 130.6 1.7
1,418.5 1,14,397.0 28,138.9 2,868.3 12.4 8.9 39.5 3.2
1,400.9 1,16,771.0 33,097.4 2,759.7 8.2 7.3 41.7 3.0
1,998.8 91,412.9 30,746.3 5,221.5 24.5 24.2 17.6 3.8
2,629.0 1,08,630.9 15,378.6 2,249.7 20.6 13.9 48.4 6.2
1,900.0 4,56,593.4 61,630.9 11,037.2 24.2 14.2 41.6 5.1
1,202.9 1,19,700.5 30,378.1 4,159.0 18.2 16.6 28.6 4.3

Shareholding Pattern

View Details
loading...

News & Analysis

All News

About Torrent Pharma

Torrent Pharmaceuticals Limited engages in the research, development, manufacturing, marketing, and distribution of branded and generic pharmaceutical formulations in India, the United States, Brazil, Germany, and internationally. The company offers...  products in various therapeutic areas, including anti-diabetic, anti-microbial, cardiovascular, urology, gynecology, oncology, gastro-intestinal, nephrology, neuro-psychiatric, cosmo-dermatology, pain management, anti-infective, and miscellaneous, as well as vitamins, minerals, and nutrients. It also provides contract manufacturing services. The company offers its products under Tedibar, Shelcal, Unienzyme, and Ahaglow brands. The company was formerly known as Trinity Laboratories and changed its name to Torrent Pharmaceuticals Limited in 1971. The company was founded in 1959 and is based in Ahmedabad, India. Torrent Pharmaceuticals Limited is a subsidiary of Torrent Investments Limited. 

  • Incorporated

    1972

  • Chairman

    Samir Mehta

  • Managing Director

    Aman Mehta

  • Group

    Torrent

  • Headquarters

    Ahmedabad, Gujarat

  • Website

    www.torrentpharma.com

FAQs for Torrent Pharma

The share price of Torrent Pharmaceuticals Ltd is ₹4,611.00 (NSE) and ₹4,616.00 (BSE) as of 19-Nov-2026 IST. Torrent Pharmaceuticals Ltd has given a return of 30.34% in the last 3 years.

The P/E ratio of Torrent Pharmaceuticals Ltd is 82.66 times as on 19-Nov-2026, a 152 premium to its peers’ median range of 32.77 times.
The P/B ratio of Torrent Pharmaceuticals Ltd is 9.56 times as on 19-Nov-2026, a 117 premium to its peers’ median range of 4.41 times.


PE & PB ratio at the end of financial year.


Year P/E Ratio P/B Ratio
2026
66.03
17.03
2025
57.28
14.42
2024
53.15
12.84
2023
41.79
8.40
2022
30.45
7.95

The 52-week high and low of Torrent Pharmaceuticals Ltd are Rs 5,250.00 and Rs 3,672.30 as of 19-Nov-2026.

Torrent Pharmaceuticals Ltd has a market capitalisation of ₹ 1,75,578 Cr as on 19-Nov-2026. As per SEBI classification, it is a Large Cap company.

Before investing in Torrent Pharmaceuticals Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.

For guidance, explore our expert-curated portfolios and Stock recommendations with Value Research Stock Advisor.
Want to explore on your own? Click here to see how this stock scores on quality, growth, valuation, and momentum.

loading...

Informed fund ideas, better judgment. Every month. Mutual Fund Insight, every month since October 2002.

Take charge. Know more. Keep more. Mutual Fund Insight helps you do all three — every month